Overlap between neurodegenerative disorders
暂无分享,去创建一个
[1] Nigel J. Cairns,et al. Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies , 1998, Neuroscience Letters.
[2] F. Tagliavini,et al. Sporadic Creutzfeldt-Jakob disease: Co-occurrence of different types of PrPSc in the same brain , 1999, Neurology.
[3] J. Gilbert,et al. Lewy body and Alzheimer pathology in a family with the amyloid-β precursor protein APP717 gene mutation , 2000, Acta Neuropathologica.
[4] D. Pollen,et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease , 1995, Nature.
[5] A. Kakita,et al. Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy. , 1998, Acta neuropathologica.
[6] B. Vogt,et al. Laminar distribution of neuron degeneration in posterior cingulate cortex in Alzheimer's disease , 2004, Acta Neuropathologica.
[7] G. Utermann. Alzheimer's disease. The apolipoprotein E connection. , 1994, Current biology : CB.
[8] A. Brice. Unstable mutations and neurodegenerative disorders , 1998, Journal of Neurology.
[9] Masanori Kato,et al. Clinicopathological multiplicity of dementia with Lewy bodies , 1999 .
[10] A. Mahadevan,et al. Infantile neuroaxonal dystrophy and giant axonal neuropathy--overlap diseases of neuronal cytoskeletal elements in childhood? , 2000, Clinical neuropathology.
[11] P. Ince,et al. Detection of Lewy Bodies in Trisomy 21 (Down's Syndrome) , 1993, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[12] R. Martins,et al. Mutations in the tau gene that cause an increase in three repeat tau and frontotemporal dementia. , 2003, Brain : a journal of neurology.
[13] A. Hakim,et al. Dementia in Parkinson disease , 1979, Neurology.
[14] D. Dickson,et al. Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease , 1991, Neurology.
[15] Charles Duyckaerts,et al. Beta A4 deposits are constant in the brain of the oldest old: an immunocytochemical study of 20 French centenarians. , 1993, Neurobiology of aging.
[16] R. Levy,et al. The Lewy-Body Variant of Alzheimer's Disease , 1993, British Journal of Psychiatry.
[17] M. Pericak-Vance,et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.
[18] P. Lantos,et al. Cortical Lewy body dementia: clinical features and classification. , 1989, Journal of neurology, neurosurgery, and psychiatry.
[19] D. Neary,et al. Dementia of frontal lobe type. , 1988, Journal of neurology, neurosurgery, and psychiatry.
[20] Hans Förstl,et al. Pick und die fokalen Hirnatrophien , 1994 .
[21] J. Trojanowski,et al. Analysis of tau haplotypes in Pick’s disease , 2002, Neurology.
[22] F. Crawford,et al. Genetic and molecular advances in Alzheimer's disease. , 1993, Trends in neurosciences.
[23] Colin L. Masters,et al. α-Synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease β-amyloid plaque cores , 1999, Neuroscience Letters.
[24] B. Chesebro. BSE and Prions: Uncertainties About the Agent , 1998, Science.
[25] D. Dickson,et al. Neurodegenerative disorders with extensive tau pathology: A comparative study and review , 1996, Annals of neurology.
[26] E. Agardh,et al. (3H)-muscimol, (3H)-nipecotic acid and (3H)-isoguvacine as autoradiographic markers for GABA neurotransmission , 2005, Journal of Neural Transmission.
[27] R. Petersen,et al. Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia , 1999, Neurology.
[28] D. Dickson,et al. Phenotypic Variability of Gerstmann-Straussler-Scheinker Disease is Associated with Prion Protein Heterogeneity , 1998, Journal of neuropathology and experimental neurology.
[29] R. Mayer,et al. Ubiquitin in Neurodegenerative Diseases , 1993, Brain pathology.
[30] Mann,et al. Amyloid β protein (Aβ) deposition in dementia with Lewy bodies: predominance of Aβ42(43) and paucity of Aβ40 compared with sporadic Alzheimer’s disease , 1998 .
[31] N. Quinn,et al. [Multiple system atrophy with Lewy bodies]. , 1995, Revue neurologique.
[32] L. Hakamies,et al. [Corticobasal degeneration]. , 2001, Duodecim; laaketieteellinen aikakauskirja.
[33] J. Brion,et al. Cortical and brainstem-type Lewy bodies are immunoreactive for the cyclin-dependent kinase 5. , 1995, The American journal of pathology.
[34] J D Fenwick,et al. Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD , 2001, Neurology.
[35] P. Lantos,et al. Quantitative variations in the pathology of 11 cases of variant Creutzfeldt-Jakob disease (vCJD). , 2002, Pathophysiology : the official journal of the International Society for Pathophysiology.
[36] S. Love,et al. Alz-50, Ubiquitin and Tau Immunoreactivity of Neurofibrillary Tangles, Pick Bodies and Lewy Bodies , 1988, Journal of neuropathology and experimental neurology.
[37] T D Bird,et al. Neuropathological heterogeneity in Alzheimer’s disease: A study of 80 cases using principal components analysis , 2000, Neuropathology : official journal of the Japanese Society of Neuropathology.
[38] P. Lantos,et al. The spatial patterns of prion protein deposits in Creutzfeldt–Jakob disease: comparison with β-amyloid deposits in Alzheimer's disease , 2001, Neuroscience Letters.
[39] Satoshi Minoshima,et al. Alzheimer's disease versus dementia with Lewy bodies: Cerebral metabolic distinction with autopsy confirmation , 2001, Annals of neurology.
[40] C. Masters,et al. Gerstmann–Sträussler–Scheinker syndrome,fatal familial insomnia, and kuru: a review ofthese less common human transmissiblespongiform encephalopathies , 2001, Journal of Clinical Neuroscience.
[41] P. Brown,et al. Coexistence of Creutzfeldt‐Jakob disease and Alzheimer's disease in the same patient , 1990, Neurology.
[42] Hans Förstl. Alzheimer's disease: the size of the problem, clinical manifestation and heterogeneity. , 1998, Journal of neural transmission. Supplementum.
[43] Masanori Kato,et al. An autopsied case of Down syndrome with Alzheimer pathology and α‐synuclein immunoreactivity , 1999 .
[44] I Litvan,et al. Progressive supranuclear palsy and corticobasal degeneration. , 2011 .
[45] R. Armstrong,et al. The identification of pathological subtypes of Alzheimer's disease using cluster analysis , 2004, Acta Neuropathologica.
[46] J. Trojanowski,et al. Strategies for Improving the Postmortem Neuropathological Diagnosis of Alzheimer’s Disease , 1997, Neurobiology of Aging.
[47] J. Price,et al. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease , 1991, Neurobiology of Aging.
[48] A. Dürr,et al. Clinical and molecular advances in autosomal dominant cerebellar ataxias: from genotype to phenotype and physiopathology , 2000, European Journal of Human Genetics.
[49] Hans Förstl,et al. Diagnostic confirmation, severity, and subtypes of Alzheimer's disease , 2005, European Archives of Psychiatry and Clinical Neuroscience.
[50] E. Perry,et al. Senile dementia of Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tau protein. , 1994, Dementia.
[51] K. Beyreuther,et al. Alzheimer's amyloid precursor protein-positive degenerative neurites exist even within kuru plaques not specific to Alzheimer's disease. , 1991, The American journal of pathology.
[52] I. Shoulson,et al. Coexistence of Huntington’s disease and familial amyotrophic lateral sclerosis: case presentation , 1996, Acta Neuropathologica.
[53] D. Dickson,et al. Neuropathologic Overlap of Progressive Supranuclear Palsy, Pick's Disease and Corticobasal Degeneration , 1996, Journal of neuropathology and experimental neurology.
[54] Kyoko Suzuki,et al. Neuropathological evaluation and apolipoprotein E gene polymorphism analysis in diffuse Lewy body disease , 1996, Journal of the Neurological Sciences.
[55] S. Hirai,et al. Presence of apolipoprotein E on extracellular neurofibrillary tangles and on meningeal blood vessels precedes the Alzheimer β-amyloid deposition , 2004, Acta Neuropathologica.
[56] Florence Pasquier,et al. Early diagnosis of dementia: neuropsychology , 1999, Journal of Neurology.
[57] J. Schneider,et al. Regional Variation in the Distribution of Apolipoprotein E and Aβ in Alzheimer's Disease , 1995 .
[58] S. Kashiwagi,et al. Current status and controversies in the inhalation protocols for the Xenon CT CBF method , 1996, Acta neurologica Scandinavica. Supplementum.
[59] A. Pick. Über einen weiteren Symptomenkomplex im Rahmen der Dementia senilis, bedingt durch umschriebene stärkere Hirnatrophie (gemischte Apraxie). , 1906 .
[60] J. Poirier,et al. Apolipoprotein E, Plaques, Tangles and Cholinergic Dysfunction in Alzheimer's Disease a , 1996, Annals of the New York Academy of Sciences.
[61] D. Mann,et al. Deposition of amyloid (A4) protein within the brains of persons with dementing disorders other than Alzheimer's disease and Down's syndrome , 1990, Neuroscience Letters.
[62] P. Lantos,et al. Beta-Amyloid Deposition in the Temporal Lobe of Patients with Dementia with Lewy Bodies: Comparison with Non-Demented Cases and Alzheimer’s Disease , 2000, Dementia and Geriatric Cognitive Disorders.
[63] B. Steinhoff,et al. Patients with Alzheimer's disease and dementia with Lewy bodies mistaken for Creutzfeldt-Jakob disease , 2001, Journal of neurology, neurosurgery, and psychiatry.
[64] P. Lantos,et al. What does the study of the spatial patterns of pathological lesions tell us about the pathogenesis of neurodegenerative disorders? , 2001, Neuropathology : official journal of the Japanese Society of Neuropathology.
[65] T. Kitamoto,et al. The coexistence of Alzheimer's disease and Creutzfeldt-Jakob disease in a patient with dementia of long duration , 1992, Acta Neuropathologica.
[66] S H Appel,et al. A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and alzheimer disease , 1981, Annals of neurology.
[67] L. Deecke,et al. [123I]β‐CIT spect in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration , 2000, Movement disorders : official journal of the Movement Disorder Society.
[68] M. Mullan,et al. Genetics and molecular advances in Alzheimer's disease , 1993, Trends in Neurosciences.
[69] J. Trojanowski,et al. Purification and characterization of Lewy bodies from the brains of patients with diffuse Lewy body disease. , 1996, The American journal of pathology.
[70] B. Steinhoff,et al. Current clinical diagnosis in Creutzfeldt‐Jakob disease: Identification of uncommon variants , 2000, Annals of neurology.
[71] J. Trojanowski,et al. The Neuropathology of a Chromosome 17-Linked Autosomal Dominant Parkinsonism and Dementia (“Pallido-Ponto-Nigral Degeneration”) , 1998, Journal of neuropathology and experimental neurology.
[72] P. Lantos,et al. The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. , 1994, Brain : a journal of neurology.
[73] D. Dickson,et al. Ultrastructural instability of paired helical filaments from corticobasal degeneration as examined by scanning transmission electron microscopy. , 1996, The American journal of pathology.
[74] S. Duckett,et al. Origins of the Creutzfeldt and Jakob concept. , 1999, Journal of the history of the neurosciences.
[75] Hans Förstl. The Lewy body variant of Alzheimer’s disease: clinical, pathophysiological and conceptual issues , 1999, European Archives of Psychiatry and Clinical Neuroscience.
[76] M. Pericak-Vance,et al. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[77] I Vuillaume,et al. Simple Nonisotopic Assays for Detection of (CAG)n Repeats Expansions Associated With Seven Neurodegenerative Disorders , 1998, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[78] P. Scheltens,et al. White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer’s disease, vascular dementia, and normal aging , 1999, Journal of neurology, neurosurgery, and psychiatry.
[79] H. Möller,et al. The case described by Alois Alzheimer in 1911 , 1998, European Archives of Psychiatry and Clinical Neuroscience.
[80] A. Kertesz,et al. Arnold Pick and German neuropsychiatry in Prague. , 1996, Archives of neurology.
[81] K. Kosaka,et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) , 1996, Neurology.
[82] L. Gustafson. Frontal lobe degeneration of non-Alzheimer type. II. Clinical picture and differential diagnosis , 1998 .
[83] D. Perl,et al. Alzheimer's disease and parkinson's disease: Distinct entities or extremes of a spectrum of neurodegeneration? , 1998, Annals of neurology.
[84] M. Palmer,et al. Prion diseases in humans and their relevance to other neurodegenerative diseases. , 1993, Dementia.
[85] W. Kirschbaum. Jakob-Creutzfeldt disease : spastic pseudosclerosis, A. Jakob; Heidenhain syndrome; subacute spongiform encephalopathy , 1968 .
[86] Jeffrey L. Cummings,et al. Cognitive and behavioral heterogeneity in Alzheimer’s disease: seeking the neurobiological basis , 2000, Neurobiology of Aging.
[87] D. Gajdusek,et al. Mixed features of Alzheimer disease and Creutzfeldt-Jakob disease in a family with a presenilin 1 mutation in chromosome 14 , 1996 .
[88] A Brun,et al. Frontal lobe degeneration of non-Alzheimer type. I. Neuropathology. , 1987, Archives of gerontology and geriatrics.
[89] F. Tagliavini,et al. Alzheimer patients and Down patients: Cerebral preamyloid deposits differ ultrastructurally and histochemically from the amyloid of senile plaques , 1989, Neuroscience Letters.
[90] P. Hof,et al. Dementia lacking distinctive histopathology: clinicopathological evaluation of 32 cases , 2004, Acta Neuropathologica.
[91] J. Foncin,et al. [Association of Alzheimer's disease and Creutzfeldt-Jakob's disease (author's transl)]. , 1977, Acta neurologica Belgica.
[92] H. Vinters. Cerebral amyloid angiopathy and alzheimer's disease: two entities or one? , 1992, Journal of the Neurological Sciences.
[93] H. Chui,et al. Clinical subtypes of dementia of the Alzheimer type , 1985, Neurology.
[94] D W Dickson,et al. Neuropathology of Alzheimer's disease and other dementias. , 2001, Clinics in geriatric medicine.
[95] J. Hardy,et al. Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene , 1991, Nature.
[96] P. Lantos,et al. Laminar distribution of Pick bodies, Pick cells and Alzheimer disease pathology in the frontal and temporal cortex in Pick’s disease , 1999, Neuropathology and applied neurobiology.
[97] A. Brun,et al. A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study , 1986, Annals of neurology.
[98] L. Thal,et al. The Lewy body variant of Alzheimer's disease , 1990, Neurology.
[99] D. Neary. Dementia of Frontal Lobe Type , 1990, Journal of the American Geriatrics Society.
[100] J. Touchon,et al. Heterogeneity in senile dementia of the Alzheimer type: individual differences, progressive deterioration or clinical sub-types? , 1992, Journal of clinical epidemiology.
[101] The spatial patterns of β/A4 deposit subtypes in Down's syndrome , 1994 .
[102] A. Roses,et al. Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. , 1994, The Journal of clinical investigation.
[103] P. Blumbergs,et al. Microtubule-associated protein 5 is a component of Lewy bodies and Lewy neurites in the brainstem and forebrain regions affected in Parkinson's disease , 1995, Acta Neuropathologica.
[104] M. Hutton,et al. Phenotypic correlations in FTDP-17 , 2001, Neurobiology of Aging.
[105] I. McKeith,et al. A Comparison of Medial and Lateral Temporal Lobe Atrophy in Dementia with Lewy Bodies and Alzheimer’s Disease: Magnetic Resonance Imaging Volumetric Study , 2001, Dementia and Geriatric Cognitive Disorders.
[106] H. Möller,et al. Rediscovery of the case described by Alois Alzheimer in 1911: historical, histological and molecular genetic analysis , 1997, Neurogenetics.
[107] P. Lantos,et al. Are pathological lesions in neurodegenerative disorders the cause or the effect of the degeneration? , 2002, Neuropathology : official journal of the Japanese Society of Neuropathology.
[108] C. Duyckaerts,et al. Apolipoprotein E allele ε4 is linked to increased deposition of the amyloid β-peptide (A-β) in cases with or without Alzheimer's disease , 1994, Neuroscience Letters.
[109] R. Armstrong. β-Amyloid Plaques: Stages in Life History or Independent Origin? , 1998, Dementia and Geriatric Cognitive Disorders.
[110] T. Pillot,et al. Molecular basis of Alzheimer’s disease , 2007, Molecular Biology.
[111] M. Gaviria,et al. [Fronto-temporal dementia]. , 2000, Actas espanolas de psiquiatria.
[112] A. Aguzzi,et al. Prion research: the next frontiers , 1997, Nature.
[113] C. Heizmann,et al. Parvalbumin-immunoreactive neurons in the cortex in Pick's disease , 1991, Journal of Neurology.
[114] S. Sorbi,et al. Genetic risk factors in familial Alzheimer's disease , 2001, Mechanisms of Ageing and Development.
[115] J. Lowe,et al. Amyotrophic lateral sclerosis: current issues in classification, pathogenesis and molecular pathology. , 1998, Neuropathology and applied neurobiology.
[116] R. Armstrong,et al. Beta-amyloid deposition in the medial temporal lobe in elderly non-demented brains and in Alzheimer's disease. , 1995, Dementia.
[117] P. Lantos,et al. β-Amyloid (Aβ) deposition in the medial temporal lobe of patients with dementia with Lewy bodies , 1997, Neuroscience Letters.
[118] C. van Broeckhoven,et al. Familial Creutzfeldt-Jakob disease in a patient carrying both a presenilin 1 missense substitution and a prion protein gene insertion , 2000, Journal of Neurology.
[119] Ian G. McKeith,et al. Patients with a novel neurofilamentopathy: dementia with neurofilament inclusions , 2003, Neuroscience Letters.
[120] K. Jellinger,et al. Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob disease , 1998, Acta Neuropathologica.
[121] B. Steinhoff,et al. How to improve the clinical diagnosis of Creutzfeldt-Jakob disease. , 1999, Brain : a journal of neurology.
[122] G. Glenner,et al. Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. , 1984, Biochemical and biophysical research communications.
[123] P Falkai,et al. Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores. , 1999, Neuroscience letters.
[124] D. Knopman,et al. An overview of common non-Alzheimer dementias. , 2001, Clinics in geriatric medicine.
[125] H. Möller,et al. Histopathology and APOE genotype of the first Alzheimer disease patient, Auguste D. , 1998, Neurogenetics.
[126] M. Gearing,et al. Corticobasal degeneration , 1997, Neurology.
[127] J. Hardy,et al. Lewy bodies in Alzheimer's disease in which the primary lesion is a mutation in the amyloid precursor protein , 1994, Neuroscience Letters.
[128] J. Morris,et al. The nosology of dementia. , 2000, Neurologic clinics.
[129] M. Rossor. Parkinson's disease and Alzheimer's disease as disorders of the isodendritic core. , 1981, British medical journal.
[130] A. Lang,et al. Motor neuron disease‐inclusion dementia presenting as cortical‐basal ganglionic degeneration , 1999, Movement disorders : official journal of the Movement Disorder Society.
[131] R. van Reekum,et al. Dementia with Lewy bodies in Down's syndrome , 2001, International journal of geriatric psychiatry.
[132] W. Spielmeyer. Die Histopathologische Forschung in der Psychiatrie , 1922, Klinische Wochenschrift.
[133] E. Kosno-Kruszewska,et al. Lewy body variant of Alzheimer's disease and Alzheimer's disease: a comparative immunohistochemical study. , 2001, Folia neuropathologica.
[134] Y. Ihara,et al. Apolipoprotein E genotype, Alzheimer's pathologies and related gene expression in the aged population. , 1995, Brain research. Molecular brain research.
[135] I Litvan,et al. What can artificial neural networks teach us about neurodegenerative disorders with extrapyramidal features? , 1996, Brain : a journal of neurology.
[136] Hitoshi Takahashi,et al. Accumulation of α-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy , 1998, Acta Neuropathologica.
[137] G. Schellenberg,et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus , 1995, Science.
[138] A. Alzheimer. Uber eine eigenartige Erkrankung der Hirnrinde , 1907 .
[139] K. Watabe,et al. Immunohistochemistry of neuronal inclusions in the cerebral cortex and brain‐stem in Lewy body disease , 1993, Acta pathologica japonica.
[140] S. M. Sumi,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.
[141] K. Jellinger,et al. Neuropathology of Alzheimer's disease: a critical update. , 1998, Journal of neural transmission. Supplementum.
[142] K. Blennow,et al. Clinical subgroups of the Alzheimer syndrome , 1996, Acta neurologica Scandinavica. Supplementum.
[143] P. Righetti,et al. Two‐dimensional mapping of three phenotype‐associated isoforms of the prion protein in sporadic Creutzfeldt‐Jakob disease , 2002, Electrophoresis.
[144] H. Kretzschmar,et al. Die neuropathologische Diagnostik neurodegenerativer und demenzieller Krankheiten , 2000, Der Pathologe.
[145] Charles Duyckaerts,et al. Subtypes and differential laminar distributions of βA4 deposits in Alzheimer's disease: relationship with the intellectual status of 26 cases , 2004, Acta Neuropathologica.
[146] R. Mantegna,et al. Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome). , 1995, Proceedings of the National Academy of Sciences of the United States of America.